Certified by Founder Lodge
Superluminal Medicines Inc.
United States - Boston, MA
START UP
1 Disclosed Funding Rounds $33,000,000
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Superluminal Medicines is a Boston-based generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 04 ,2023 | Seed | $33,000,000 |
RA Capital Management, L.P.
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Bland Company | $2,670,000 | (Feb 18, 2026)
Tangible | $4,300,000 | (Feb 18, 2026)
Helia Care, Inc. | $3,000,000 | (Feb 18, 2026)
Daffodil Health Corp | $16,300,000 | (Feb 18, 2026)
FYLD | $41,000,000 | (Feb 18, 2026)
